Recently, the website of the State Food and Drug Administration issued a notice saying that eight batches of Chinese herbal pieces produced by eight enterprises, including Jiangsu Fuyuan Chinese Herbal Pieces Co., Ltd., were unqualified after inspection by China Food and Drug Inspection Institute, and the relevant provincial food and drug supervision departments have taken control measures such as seizure.

According to the circular, eight batches of ginseng produced by Jiangsu Fuyuan Chinese Herbal Pieces Co., Ltd., Anhui Xiehecheng Pharmaceutical Herbal Pieces Co., Ltd., Bozhou Jinshaotang Chinese Herbal Pieces Co., Ltd., anguo city Sheng Hui Chinese Herbal Pieces Co., Ltd., Guangdong Mattel Pharmaceutical Co., Ltd., Sichuan Yuanshangcao Chinese Herbal Pieces Co., Ltd. and Wushan County Pharmaceutical Company Chinese Herbal Pieces Factory were unqualified. Unqualified items are pesticide residues (see annex for details).

the relevant provincial food and drug supervision and administration departments have taken control measures such as sealing up and detaining the above-mentioned unqualified Chinese herbal pieces, requiring enterprises to suspend the sale and use, recall the products and make rectification.

According to the circular, china food and drug administration requires the provincial food and drug supervision and administration departments where the relevant units are located to initiate an investigation on the illegal activities of the above-mentioned enterprises in producing and selling substandard drugs in accordance with Articles 73, 74 and 75 of the Drug Administration Law of the People's Republic of China, make public the handling results of the relevant units in producing and selling substandard drugs within three months, and report relevant information in time.

these producers must be severely punished.